Brief: SynAct Pharma raises proceeds of SEK 1 mln through exercise of warrants of series TO
March 31 (Reuters) - SYNACT PHARMA AB SYNACT.ST :
* RAISES PROCEEDS OF 1,007,539.20 SWEDISH CROWNS BEFORE
ISSUE COSTS THROUGH EXERCISE OF WARRANTS OF SERIES TO
Source text: http://bit.ly/2oFN3ft
Further company coverage: SYNACT.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on SynAct Pharma AB
See all newsBrief: SynAct: Shareholding Board, Management Sign Lock-Up Agreements
Sweden's SynAct Pharma posts wider Q1 net loss as expenses rise
Brief: SynAct Pharma Q1 Sales SEK 0
Brief: SynAct Pharma Carries Out Directed Issue Of New Shares
Brief: Synact Pharma Appoints Ann Kristin Led As CFO Effective March 2026